Literature DB >> 17895457

Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease.

Annie On On Chan1, Man Hong Jim, Kwok Fai Lam, Jeffrey S Morris, David Chun Wah Siu, Teresa Tong, Fook Hong Ng, Siu Yin Wong, Wai Mo Hui, Chi Kuen Chan, Kam Chuen Lai, Ting Kin Cheung, Pierre Chan, Grace Wong, Man Fung Yuen, Yuk Kong Lau, Stephen Lee, Ming Leung Szeto, Benjamin C Y Wong, Shiu Kum Lam.   

Abstract

CONTEXT: Colorectal neoplasm and coronary artery disease (CAD) share similar risk factors, and their co-occurrence may be associated.
OBJECTIVES: To investigate the prevalence of colorectal neoplasm in patients with CAD in a cross-sectional study and to identify the predisposing factors for the association of the 2 diseases. DESIGN, SETTING, AND PARTICIPANTS: Patients in Hong Kong, China, were recruited for screening colonoscopy after undergoing coronary angiography for suspected CAD during November 2004 to June 2006. Presence of CAD (n = 206) was defined as at least 50% diameter stenosis in any 1 of the major coronary arteries; otherwise, patients were considered CAD-negative (n = 208). An age- and sex-matched control group was recruited from the general population (n = 207). Patients were excluded for use of aspirin or statins, personal history of colonic disease, or colonoscopy in the past 10 years. MAIN OUTCOME MEASURES: The prevalence of colorectal neoplasm in CAD-positive, CAD-negative, and general population participants was determined. Bivariate logistic regression was performed to study the association between colorectal neoplasm and CAD and to identify risk factors for the association of the 2 diseases after adjusting for age and sex.
RESULTS: The prevalence of colorectal neoplasm in the CAD-positive, CAD-negative, and general population groups was 34.0%, 18.8%, and 20.8% (P < .001 by chi2 test), prevalence of advanced lesions was 18.4%, 8.7%, and 5.8% (P < .001), and prevalence of cancer was 4.4%, 0.5%, and 1.4% (P = .02), respectively. Fifty percent of the cancers in CAD-positive participants were early stage. After adjusting for age and sex, an association still existed between colorectal neoplasm and presence of CAD (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.25-2.70; P = .002) and between advanced lesions and presence of CAD (OR, 2.51; 95% CI, 1.43-4.35; P = .001). The metabolic syndrome (OR, 5.99; 95% CI, 1.43-27.94; P = .02) and history of smoking (OR, 4.74; 95% CI, 1.38-18.92; P = .02) were independent factors for the association of advanced colonic lesions and CAD.
CONCLUSIONS: In this study population undergoing coronary angiography, the prevalence of colorectal neoplasm was greater in patients with CAD. The association between the presence of advanced colonic lesions and CAD was stronger in persons with the metabolic syndrome and a history of smoking.

Entities:  

Mesh:

Year:  2007        PMID: 17895457     DOI: 10.1001/jama.298.12.1412

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  40 in total

1.  Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.

Authors:  Yoshikuni Kawaguchi; Scott Kopetz; Timothy E Newhook; Mario De Bellis; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Clin Cancer Res       Date:  2019-06-20       Impact factor: 12.531

2.  Digoxin use and the risk for colorectal cancer.

Authors:  Ben Boursi; Kevin Haynes; Ronac Mamtani; Yu-Xiao Yang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-09-29       Impact factor: 2.890

3.  Bowel movement frequency, oxidative stress and disease prevention.

Authors:  Alphons J M Vermorken; Emmanuel Andrès; Yali Cui
Journal:  Mol Clin Oncol       Date:  2016-08-10

4.  The comparison of the clinical manifestations and risk factors of colorectal cancer and adenomas: results from a colonoscopy-based study in southern Chinese.

Authors:  Liyun Huang; Xinying Wang; Wei Gong; Yinglong Huang; Bo Jiang
Journal:  Int J Colorectal Dis       Date:  2010-08-03       Impact factor: 2.571

Review 5.  Primary prevention of colorectal cancer.

Authors:  Andrew T Chan; Edward L Giovannucci
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

6.  The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer.

Authors:  Michela Murdocca; Ruggiero Mango; Sabina Pucci; Silvia Biocca; Barbara Testa; Rosamaria Capuano; Roberto Paolesse; Massimo Sanchez; Augusto Orlandi; Corrado di Natale; Giuseppe Novelli; Federica Sangiuolo
Journal:  Oncotarget       Date:  2016-03-22

7.  Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.

Authors:  Andrew T Chan; Shuji Ogino; Edward L Giovannucci; Charles S Fuchs
Journal:  Gastroenterology       Date:  2010-11-27       Impact factor: 22.682

8.  Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

Authors:  Yoshikuni Kawaguchi; Heather A Lillemoe; Elena Panettieri; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2019-05-02       Impact factor: 6.113

9.  Dietary habits of colorectal neoplasia patients in comparison to their first-degree relatives.

Authors:  Ivana Mikoviny Kajzrlikova; Petr Vitek; Josef Chalupa; Petr Dite
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

10.  Components of metabolic syndrome and metachronous colorectal neoplasia.

Authors:  Erin L Ashbeck; Elizabeth T Jacobs; María Elena Martínez; Eugene W Gerner; Peter Lance; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.